PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)
- Equity | Health/Biotechnology Funds
- Loading...
Best Fit Health/Biotechnology Funds ETFs
U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
| Best Fit Scorecard | |
|---|---|
| Costs | Typical |
| Tracking Error | Good |
| Bid/Ask Ratio | Excellent |
| Holdings Diversity | Typical |
Fund Description
The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Fund Snapshot Updated 06.17.2013
| Previous Close | $28.80 | Expense Ratio | 0.60% |
| YTD Return | 26.1% | Avg. 30-Day Volume | 25,111 |
| 1-Year Return | 30.5% | Market Cap | Loading... |
| Bid | $28.80 | Shares Outstanding | 5,550,000 |
| Ask | $28.81 | Dividends | $0.00 |
| Top 10 Holdings | |
|---|---|
| Waters Corp (WAT) | 5.29% |
| Illumina Inc (ILMN) | 5.13% |
| Life Technologies Corp (LIFE) | 5.12% |
| Amgen Inc (AMGN) | 5.04% |
| Sigma Aldrich Corp (SIAL) | 4.99% |
| Regeneron Pharmaceuticals (REGN) | 4.91% |
| Gilead Sciences Inc (GILD) | 4.79% |
| Biogen Idec Inc (BIIB) | 4.47% |
| Isis Pharmaceuticals Inc (ISIS) | 2.93% |
| Viropharma Inc (VPHM) | 2.93% |
| % of Total Holdings | 45.60% |
